Boardroom Alpha
Boardroom Alpha
TASK · Current Report (Form 8-K) · Filed March 17, 2026

Taskus Inc — Current Report (Form 8-K)

Form
8-K
Filed
March 17, 2026
Period
Mar 11, 2026
Ticker
TASK
Accession
0001193125-26-111007
Boardroom Alpha · Filing insights

TaskUs refinances debt via a new $500M term loan and $100M revolver to fund a special dividend.

About Taskus Inc
Market cap
$593M
1Y TSR
−43.0%
3Y TSR
−6.1%
Board grade
C-
Sector
Technology
CEO
Bryce Maddock
Last annual meeting: May 21, 2026 · View full Taskus Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 11, 2026

 

 

TaskUs, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-40482   83-1586636

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

1650 Independence Drive, Suite 100

New Braunfels, Texas 78132

(Address of Principal Executive Offices) (Zip Code)

(888) 400-8275

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Class A Common Stock, par value $0.01 per share   TASK   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01 Entry into a Material Definitive Agreement.

In connection with the previous announcement of TaskUs, Inc. (the “Company”), regarding its secured commitments for a comprehensive refinancing of its existing credit facilities, on March 11, 2026 (the “Amendment Date”), TU MidCo, Inc. (“MidCo”), a wholly-owned subsidiary of the Company, TU BidCo, Inc. (the “Borrower”), a direct wholly-owned subsidiary of MidCo, and certain of the Borrower’s other subsidiaries (together with MidCo, the “Guarantors”) entered into a Second Amended and Restated Credit Agreement (the “Second Amended and Restated Credit Agreement”) with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent. The Second Amended and Restated Credit Agreement amends and restates the existing Amended and Restated Credit Agreement, initially dated as of September 25, 2019 (as amended and restated on September 7, 2022 and as further amended, restated, amended and restated, supplemented or otherwise modified prior to the Amendment Date, the “Existing Credit Agreement”) among MidCo, the Borrower, the other Guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.

On the Amendment Date, the Borrower borrowed term loans in an amount equal to $500,000,000 and received revolving commitments in an amount equal to $100,000,000. The proceeds of the term loans were used to refinance outstanding borrowings under the Existing Credit Agreement and to pay transaction fees and expenses and will be used to fund the previously announced special cash dividend to the Company’s stockholders. The Borrower will be able to draw on the revolving commitments for working capital and general corporate purposes (including permitted acquisitions).

Loans made under the Second Amended and Restated Credit Agreement will bear interest, at the Borrower’s option, either at (i) a Term SOFR rate plus a margin of 2.75% per annum, subject to a Term SOFR rate floor of 0.00% or (ii) an alternative base rate plus a margin of 1.75% per annum, subject to an alternative base rate floor of 1.00%.

Commencing with the fiscal quarter ending September 30, 2026, the Borrower will be required to make quarterly amortization payments on the last business day of each fiscal quarter in an aggregate principal amount equal to 1.25% of the original principal amount of the term loans for the fiscal quarter ending September 30, 2026 through the fiscal quarter ending March 31, 2029, 1.875% of the original principal amount of the term loans for the fiscal quarter ending June 30, 2029 through the fiscal quarter ending March 31, 2030 and 2.50% of the original principal amount of the term loans thereafter until the maturity date of the term loans. The term loans and revolving commitments under the Second Amended and Restated Credit Agreement will mature on the date that is five years following the Amendment Date.

The Second Amended and Restated Credit Agreement includes a financial maintenance covenant, tested as of the last day of any fiscal quarter, consisting of a consolidated total net leverage ratio not to exceed 3.25 to 1.00.

In addition, the Second Amended and Restated Credit Agreement amended certain covenants of the Existing Credit Agreement to generally provide additional flexibility for the Borrower. All other terms and collateral securing the loans will remain substantially the same as the Existing Credit Agreement except as otherwise amended by the Second Amended and Restated Credit Agreement.

The foregoing description of the Second Amended and Restated Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Second Amended and Restated Credit Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    TASKUS, INC.
    By:  

/s/ Balaji Sekar

      Name: Balaji Sekar
      Title: Chief Financial Officer
Date: March 17, 2026      
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Taskus Inc (TASK)

Reference

Frequently asked questions

When did Taskus Inc file this 8-K?
Taskus Inc (TASK) filed this Current Report (Form 8-K) with the SEC on March 17, 2026. The accession number assigned by EDGAR is 0001193125-26-111007.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
TaskUs refinances debt via a new $500M term loan and $100M revolver to fund a special dividend. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Taskus Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Taskus Inc has filed under CIK 1829864, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer